US FDA approves Moderna's next-generation COVID vaccine for adults
The US Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.
The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors defined by the Centers for Disease Control and Prevention, Moderna said in a statement.
The company said it expects to have the vaccine, called mNEXSPIKE, available for the 2025-2026 respiratory virus season.
'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' CEO Stephane Bancel said in the statement.
The Department of Health and Human Services, under the leadership of long-time vaccine skeptic Robert F. Kennedy Jr., is tightening regulatory scrutiny on vaccines.
The FDA said on May 20 it planned to require drugmakers to test their COVID booster shots against an inert placebo in healthy adults under 65 for approval, effectively limiting them to older adults and those at risk of developing severe illness.
The Moderna vaccine can be stored in refrigerators rather than freezers, to offer longer shelf life and make distribution easier, especially in developing countries where supply-chain issues could hamper vaccination drives.
The Centers for Disease Control and Prevention, which Kennedy also oversees, said on Thursday that COVID vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Kennedy's announcement days earlier that the agency would remove the shots from its immunization schedule.
The CDC announcement eases investor concern to some extent, analysts say, as it keeps the existing framework for older adults and at-risk people who generally seek out the shots.
FDA leaders have said 100 million to 200 million Americans would still be eligible for annual shots.
Moderna is betting on its newer messenger RNA vaccines as it grapples with waning demand for its original COVID vaccine Spikevax and lower-than-expected uptake of its respiratory syncytial virus vaccine.
The approval for mNEXSPIKE was based on late-stage trial data, which showed the shot was not inferior in efficacy compared to Spikevax in individuals aged 12 years and older.
The shot also showed superior efficacy compared to Spikevax in adults 18 years of age and older in the study.
Kennedy has kickstarted a major overhaul of health departments, laying off thousands of employees to align with President Donald Trump's goal of dramatically shrinking the federal government. This has further ignited worries about potential disruptions to the regulatory review of treatments and vaccines.
The CDC's outside panel of vaccine experts in April discussed recommending the booster shots only for populations at risk of severe COVID-19 for the upcoming immunization campaign.
The FDA approved Novavax's COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Conditions that constitute additional risk range from illnesses such as diabetes and heart disease to behaviors like physical inactivity and substance abuse, according to the CDC.
While Moderna's shots, as well as Pfizer-BioNTech's Comirnaty, are mRNA-based, Novavax's vaccine is protein-based and takes longer to manufacture.
Moderna this month withdrew an application seeking approval for its flu-and-COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ArabGT
an hour ago
- ArabGT
The Dodge Durango SRT Hellcat Is Still Going Strong in 2026
What began as a one-year special edition has turned into a lasting chapter in Dodge's muscle SUV saga. Initially launched as a 2021 limited-run model, the Durango SRT Hellcat was supposed to be a rare beast — a three-row family hauler with the heart of a drag racer. But its overwhelming popularity changed everything. After a brief pause, Dodge brought it back in 2023, and now, against all odds (and some owner complaints), the 2026 Durango SRT Hellcat is entering its fourth consecutive year of production — and fifth year overall. How a 'One-Year Only' Icon Became a Staple When Dodge, under the Stellantis umbrella, introduced the Durango SRT Hellcat in 2021, it was marketed as the ultimate SUV — packing a supercharged 6.2-liter V8 that delivered 710 horsepower and 875 Nm of torque. All that power was sent to all four wheels via an eight-speed automatic transmission, turning the Durango into one of the fiercest utility vehicles on the market. At the time, customers rushed to own what they thought would be a true collector's item. However, with demand far exceeding expectations, Dodge couldn't resist bringing it back. The return in 2023 reignited excitement, but also stirred frustration among early adopters who believed they had something rare. Regardless, the Durango Hellcat's blend of performance, practicality, and sheer audacity made it impossible to shelve. 2026: Same Heart, Same Spirit While Dodge has yet to disclose every detail about the 2026 Durango SRT Hellcat, it has confirmed the model will remain in the lineup. So far, the essentials remain unchanged: Engine : Supercharged 6.2-liter V8, 710 hp, 875 Nm of torque Transmission : 8-speed automatic Chassis tuning : Performance-tuned suspension and steering for handling agility despite its hefty 2,600 kg curb weight Exterior : Aggressive front grille, bold air vents, signature Hellcat emblems, and 20-inch wheels Interior: 12.3-inch Uconnect 5 touchscreen, digital instrument cluster, Nappa leather sport seats with red stitching, and subtle engine acoustics 2026 Pricing Remains Steady Despite being 15 years into the current-generation Durango's lifespan, Dodge is holding base prices steady for 2026. The Durango GT, powered by a V6, starts at $40,490. The R/T trim remains at $51,990, with new 'Blacktop Redline' appearance options adding $3,495. Optional upgrades include the $5,990 Tow N Go Package — bringing many of the SRT 392's chassis enhancements minus the engine — and a $1,195 Tow Package with features like a trailer brake controller. Why the Durango Hellcat Isn't Going Anywhere Though initially billed as a short-lived experiment, it's clear Dodge used the 'limited edition' label to gauge market interest. Once it became obvious that buyers were hungry for a muscle-bound SUV with a traditional roar, the brand doubled down. Now, the Durango SRT Hellcat serves as a modern muscle icon that refuses to bow out. Looking Beyond 2026 More details on the 2026 model are expected later in 2025, potentially including new color choices, minor tweaks to the exhaust, or upgrades to the AWD system's electronics. But the real question looms: When will the Durango SRT Hellcat finally end? And with so many iterations, could it lose the special status it once had? For now, the Durango Hellcat remains a living legend — an unapologetic celebration of power in an SUV world increasingly leaning toward quiet electrification.
ArabGT
an hour ago
- ArabGT
Why Hyundai Prices Are Going Up in 2025
Unofficial reports suggest that Hyundai prices across its 2025 vehicle lineup in the US are set to increase by around 1%. While the percentage may seem small, it translates to an average rise of roughly $400 — or about 1,500 Saudi riyals — on a vehicle priced at $40,000. This upcoming adjustment reflects growing pressure on global automakers, as the industry continues to face soaring costs for raw materials, logistics, and electronic components. Legacy tariffs introduced under President Trump are also contributing to the financial strain. What's Driving the Hyundai Price Increase? Hyundai, like many of its competitors, is navigating rising production expenses tied to materials such as aluminum, steel, and semiconductor chips — all essential to modern vehicles. In a formal statement, a company spokesperson said Hyundai only made this pricing decision after a thorough review of manufacturing and distribution costs to ensure continued quality and customer support. Prior to the anticipated increase, Hyundai prices in the US were approximately: 2025 Hyundai Tucson – $27,000 (≈ 101,250 SAR) 2025 Hyundai Sonata – $25,500 (≈ 95,625 SAR) 2025 Hyundai Palisade – $35,000 (≈ 131,250 SAR) 2025 Hyundai Ioniq 5 – $45,000 (≈ 168,750 SAR) After a 1% increase, expected Hyundai prices would look like this: Tucson – ~$27,270 (≈ 102,262 SAR) Sonata – ~$25,755 (≈ 96,581 SAR) Palisade – ~$35,350 (≈ 132,344 SAR) Ioniq 5 – ~$45,450 (≈ 170,438 SAR) Although the increase may seem modest, it still marks a notable shift for customers navigating a highly competitive car market. Applies to All Models — But There's Wiggle Room Hyundai clarified that the updated Hyundai prices will affect all model types — including EVs, hybrids, and traditional gasoline vehicles — with the changes taking effect for production and deliveries starting June 1, 2025. Buyers, however, may still find opportunities to save. Dealer offers, end-of-inventory sales, and various financing incentives can help cushion the impact. Whether you're eyeing a fuel-sipping Sonata Hybrid or considering the all-electric Ioniq 5, acting before the new pricing takes hold could result in significant savings. Additionally, Hyundai dealers may roll out special incentives such as cash rebates or extended low-interest financing options — up to 72 months on select models — to maintain sales momentum despite the increase in Hyundai prices. Impact on Market Position and Consumer Choices Industry experts suggest that Hyundai's measured approach to raising prices is likely intended to preserve its competitive edge without pushing buyers toward rival brands like Toyota, Nissan, Kia, or Mitsubishi. Still, if Hyundai prices rise beyond the current 1%, some consumers may explore more affordable alternatives or brands with better offers. Other manufacturers, including Ford and General Motors, are reportedly considering similar pricing strategies but are expected to wait for Q2 2025 sales data before making final moves. The expected 1% hike in Hyundai prices for 2025 models highlights the broader cost challenges facing the automotive sector. For buyers, the best advice is to plan ahead, compare incentives, and act quickly if looking to purchase before prices rise. While the increase itself isn't drastic, it underscores the changing dynamics of car pricing in today's economic climate — and raises questions about whether more adjustments are on the horizon.
Asharq Al-Awsat
an hour ago
- Asharq Al-Awsat
Trump, Xi Likely to Speak Soon on Minerals Trade Dispute, Treasury's Bessent Says
US Treasury Secretary Scott Bessent said he believes President Donald Trump and Chinese President Xi Jinping will speak soon to iron out trade issues including a dispute over critical minerals. President Donald Trump on Friday accused China of violating an agreement with the US to mutually roll back tariffs and trade restrictions for critical minerals. "What China is doing is they are holding back products that are essential for the industrial supply chains of India, of Europe. And that is not what a reliable partner does," Bessent said in an interview on Sunday with CBS' "Face the Nation." "I am confident that when President Trump and Party Chairman Xi have a call, that this will be ironed out. But the fact that they are withholding some of the products that they agreed to release during our agreement - maybe it's a glitch in the Chinese system, maybe it's intentional. We'll see after the President speaks with the party chairman." Trump said on Friday he was sure that he would speak to Xi. China said in April that the two leaders had not had a conversation recently. Asked if a talk with Xi was on Trump's schedule, Bessent said, "I believe we'll see something very soon."
